ADACHI Mitsuru 足立満

Researcher Number	10095870
Affiliation (based on the past Project Information) *help	2010 – 2013: 昭和大学, 医学部, 教授
Review Section/Research Field	Except Principal Investigator Clinical oncology / Applied pharmacology
Keywords	Except Principal Investigator 喫煙者肺癌 / 扁平上皮肺癌 / 肺扁平上皮癌 / 喫煙 / 上皮成長因子受容体 / ADAM17 / EGFR / 肺癌 / 扁平上皮癌 / ファーマコゲノミクス

Association of pharmacokinetics or pharmacogenomics with toxicity of erlotinib in patients with advanced non-small cell lung cancer
- Principal Investigator
  
  HIROSE Takashi
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Tokyo National Hospital (Clinical research)
  Showa University
The role of ADAM17 in squamous cell lung cancer
- Principal Investigator
  
  SIRAI Takao
- Project Period (FY)
  2010 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Clinical oncology
- Research Institution
  Showa University

All 2012 2011 2010

All Journal Article Presentation

[Journal Article] Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer2011
- Author(s)
  Kishida Y, Hirose T, Shirai T, Sugiyama T, Kusumoto S, Yamaoka T, Okuda K, Adachi M, Nakamura A
- Journal Title
  
  Oncol Lett.
  
  Volume: 2(5) Pages: 949-955
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small -cell lung cancer2011
- Author(s)
  Hirose T, Nakashima M, Shirai T, Kusumoto S, Sugiyama T, Yamaoka T, Okuda K, Ohnishi T, Ohmori T, Adachi M
- Journal Title
  
  Lung Cancer
  
  Volume: 73(3) Pages: 345-50
- DOI
  10.1016/j.lungcan.2010.12.015
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small -cell lung cancer?2011
- Author(s)
  Hirose T, Okuda K, Yamaoka T, Ishida K, Kusumoto S, Sugiyama T, Shirai T, Ohnshi T, Ohmori T, Adachi M
- Journal Title
  
  Lung Cancer
  
  Volume: 71(2) Pages: 224-8
- DOI
  10.1016/j.lungcan.2010.05.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small -cell lung cancer2011
- Author(s)
  Murata Y, Hirose T, Yamaoka T, Shirai T, Okuda K, Sugiyama T, Kusumoto S, Nakashima M, Ohmori T, Adachi M
- Journal Title
  
  Eur J Cancer
  
  Volume: 47(9) Pages: 1336-42
- DOI
  10.1016/j.ejca.2011.03.007
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] Phase II study of S-1,a novel oral fluoropyrimidine,and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer2011
- Author(s)
  Oki Y, Hirose T, Yamaoka T, Kusumoto S, Shirai T, Sugiyama T, Okuda K, Nakashima M, Murata Y, Ohmori T, Adachi M
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 67(4) Pages: 791-7
- DOI
  10.1007/s00280-010-1382-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Journal Article] The UGT1A1*28 genotype and the toxicity of low -dose irinotecan in patients with advanced lung cancer2010
- Author(s)
  Sugiyama T, Hirose T, Kusumoto S, Shirai T, Yamaoka T, Okuda K, Ohnishi T, Ohmori T, Adachi M
- Journal Title
  
  Oncol Res.
  
  Volume: 18(7) Pages: 337-42
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] Carboplatin+Paclitaxel+Bevacizumabによる化学療法中にIII度房室プロックをきたした肺腺癌症例2012
- Author(s)
  白井崇生, 慶瀬敬, 大木康成, 村田泰規, 楠本壮三郎, 杉山智英, 石田博雄, 中属賢尚, 奥田健太郎, 大西司, 足立満, 山岡利光, 大森亨
- Organizer
  日本肺癌学会
- Place of Presentation
  岡山
- Year and Date
  2012-11-08
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] 気道上皮細胞と非小細胞肺癌細胞におけるTACE/EGFR-リガンドを介したTNFによるEGFRのトランス活性化の機序検討(TNF transactivates phospho-tyrosine 1068 of EGFR through TACE/EGFR-ligand dependent mechanism)2011
- Author(s)
  山岡利光, 大木康成, 楠本壮三郎, 杉山智英, 白井崇生, 中属賢尚, 奥田健太郎, 慶瀬敬, 大森亨, 大西司, 足立満
- Organizer
  日本癌学会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-03
- Data Source
  KAKENHI-PROJECT-22501051
[Presentation] 進行非小細胞肺癌の生存期間が延長しているのはなぜか?2010
- Author(s)
  白井崇生, 慶瀬敬, 楠本壮三郎, 杉山智英, 中属賢尚, 山岡利光, 奥田健太郎, 大西司, 大森亨, 足立満
- Organizer
  日本肺癌学会
- Place of Presentation
  東京
- Year and Date
  2010-11-12
- Data Source
  KAKENHI-PROJECT-22501051

1. HIROSE Takashi (40307038)

# of Collaborated Projects: 2 results

# of Collaborated Products: 9 results
2. YAMAOKA Toshimitsu (40384359)

# of Collaborated Projects: 2 results

# of Collaborated Products: 9 results
3. OHMORI Tohru (10276529)

# of Collaborated Projects: 2 results

# of Collaborated Products: 8 results
4. SIRAI Takao (90384362)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
5. KADOKURA Mitsutaka (60214417)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 藤田健一 (60281820)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 佐々木康綱 (20235279)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

ADACHI Mitsuru 足立 満

Research Projects

Research Products

Co-Researchers

Association of pharmacokinetics or pharmacogenomics with toxicity of erlotinib in patients with advanced non-small cell lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The role of ADAM17 in squamous cell lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer2011

Author(s)

Journal Title

Data Source

[Journal Article] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small -cell lung cancer2011

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small -cell lung cancer?2011

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small -cell lung cancer2011

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase II study of S-1,a novel oral fluoropyrimidine,and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer2011

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The UGT1A1*28 genotype and the toxicity of low -dose irinotecan in patients with advanced lung cancer2010

Author(s)

Journal Title

Data Source

[Presentation] Carboplatin+Paclitaxel+Bevacizumabによる化学療法中にIII度房室プロックをきたした肺腺癌症例2012

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 気道上皮細胞と非小細胞肺癌細胞におけるTACE/EGFR-リガンドを介したTNFによるEGFRのトランス活性化の機序検討(TNF transactivates phospho-tyrosine 1068 of EGFR through TACE/EGFR-ligand dependent mechanism)2011

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 進行非小細胞肺癌の生存期間が延長しているのはなぜか?2010

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

ADACHI Mitsuru 足立満